Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1053074

Optimal choice of antimicrobial therapy for Pseudomonas aeruginosa urinary tract infections in outpatients


Barišić, Zvonimir; Babić-Erceg, Andrea; Borzić, Elmica; Zoranić, Vinko; Carev, Merica; Kaliterna, Vanja
Optimal choice of antimicrobial therapy for Pseudomonas aeruginosa urinary tract infections in outpatients // Int J Antimicrob Agents
Pariz, Francuska, 2002. str. S44-S45 (poster, međunarodna recenzija, sažetak, ostalo)


CROSBI ID: 1053074 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Optimal choice of antimicrobial therapy for Pseudomonas aeruginosa urinary tract infections in outpatients

Autori
Barišić, Zvonimir ; Babić-Erceg, Andrea ; Borzić, Elmica ; Zoranić, Vinko ; Carev, Merica ; Kaliterna, Vanja

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo

Izvornik
Int J Antimicrob Agents / - , 2002, S44-S45

Skup
4th European Congress of Chemotherapy and Infection

Mjesto i datum
Pariz, Francuska, 04.05.2002. - 07.05.2002

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Pseudomonas ; therapy

Sažetak
The aim of this study is to determine frequency of Pseudomonas aeruginosa urinary tract infection (UTI) in outpatient's population in South Croatia and to suggest optimal antimicrobial treatment for these patients. During 3 months long observation period, from total number of 13 158 examined urine specimens, significant bacteriuria was found in 2341 specimens. P. aeruginosa was the sixth most common isolate. It was isolated from 94 specimens (4.02%). These 94 specimens were taken from 57 different patients. Susceptibility testing was performed by disk diffusion method, and the following results were obtained: resistance to cefibuten occurred in 94.74% patients. to norfoxacin in 49.12%, to ciprofloxacin in 47.37%. to gentamicin in 42.11%, to netilmicin in 35.09%, to arnikacin in 24.56%, to ceftazidime in 3.51% and to imipenem in 1.75% patients. P. aeruginosa strains showed better susceptibility to tested parenteral antibiotics than to antibiotics for oral use which complicated treatment in outpatients. The best susceptibility was shown to irnipenem, but this drug is inappropriate for use in outpatients setting, so the best choice for treatment P. aeruginosa UTI in our outpatients is treatment with ceftazidime.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA



Citiraj ovu publikaciju:

Barišić, Zvonimir; Babić-Erceg, Andrea; Borzić, Elmica; Zoranić, Vinko; Carev, Merica; Kaliterna, Vanja
Optimal choice of antimicrobial therapy for Pseudomonas aeruginosa urinary tract infections in outpatients // Int J Antimicrob Agents
Pariz, Francuska, 2002. str. S44-S45 (poster, međunarodna recenzija, sažetak, ostalo)
Barišić, Z., Babić-Erceg, A., Borzić, E., Zoranić, V., Carev, M. & Kaliterna, V. (2002) Optimal choice of antimicrobial therapy for Pseudomonas aeruginosa urinary tract infections in outpatients. U: Int J Antimicrob Agents.
@article{article, author = {Bari\v{s}i\'{c}, Zvonimir and Babi\'{c}-Erceg, Andrea and Borzi\'{c}, Elmica and Zorani\'{c}, Vinko and Carev, Merica and Kaliterna, Vanja}, year = {2002}, pages = {S44-S45}, keywords = {Pseudomonas, therapy}, title = {Optimal choice of antimicrobial therapy for Pseudomonas aeruginosa urinary tract infections in outpatients}, keyword = {Pseudomonas, therapy}, publisherplace = {Pariz, Francuska} }
@article{article, author = {Bari\v{s}i\'{c}, Zvonimir and Babi\'{c}-Erceg, Andrea and Borzi\'{c}, Elmica and Zorani\'{c}, Vinko and Carev, Merica and Kaliterna, Vanja}, year = {2002}, pages = {S44-S45}, keywords = {Pseudomonas, therapy}, title = {Optimal choice of antimicrobial therapy for Pseudomonas aeruginosa urinary tract infections in outpatients}, keyword = {Pseudomonas, therapy}, publisherplace = {Pariz, Francuska} }




Contrast
Increase Font
Decrease Font
Dyslexic Font